Modifying myosin subfragment 1 with pPDM stabilizes a conformation that mimics the ATP-bound state, providing a stable analogue for biochemical studies of muscle contraction.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications for cardiac contractility; leaves open pPDM-S-1 as a stable model for actomyosin studies.
Myosin subfragment 1 (S-1) with its two reactive cysteine groups crosslinked by N,N'-p-phenylenedimaleimide (pPDM), is shown to be a stable analogue of S-1 X ATP and S-1 X ADP X Pi, the predominant complexes present during the steady-state hydrolysis of ATP by S-1. pPDM-S-1 binds to actin with about twice the affinity of S-1 X ATP or S-1 X ADP X Pi, whereas its affinity is 1/100th of that of S-1 X 5'-adenylyl imidodiphosphate and 1/1,000th of that of S-1 X ADP. pPDM-S-1 is also similar to S-1 X ATP and S-1 X ADP X Pi in that its binding to actin is not inhibited by troponin-tropomyosin. In contrast, the binding of S-1, S-1 X ADP, and S-1 X 5'-adenylyl imidodiphosphate to actin is markedly inhibited by troponin-tropomyosin in the absence of Ca2+ when actin is in large excess over S-1. This suggests that modifying S-1 with pPDM stabilizes a conformation which mimics that induced by the binding of ATP.
No takes yet. Share an insight, caveat, or question.
Chalovich et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: